Detailed explanation of contraindications and precautions for baclofen oral granules
Baclofen oral granules (trade nameLyvispah) is an effective drug for treating spasticity caused by multiple sclerosis. Although it is widely used, it is not suitable for all patients. Before use, patients must fully understand its contraindications and precautions to ensure the safety and effectiveness of the medication.
First, patients who are allergic to any ingredient in baclofen oral granules should definitely avoid its use. Anaphylaxis can cause serious health problems such as rashes, difficulty breathing, and even anaphylactic shock. Therefore, before use, patients must confirm that they have no allergic reaction to the ingredients of the drug. If they have any doubts, they should consult a doctor immediately and undergo an allergy test.
Abruptly stopping the use of baclofen oral granules may cause withdrawal symptoms, such as anxiety, insomnia, and seizures. This is because Baclofen has a certain degree of dependence, and the body will gradually adapt to the presence of the drug after long-term use. Therefore, patients must consult a doctor before stopping the drug and gradually reduce the dose under the guidance of the doctor to avoid the occurrence of withdrawal symptoms.
Before taking baclofen oral granules, patients should tell their doctor in detail about their medical history, including whether they have any mental illness or psychosis, epilepsy or other seizure disorders, balance problems, high blood pressure or fast heart rate, stroke or blood clots, and kidney disease. This information is critical for doctors to evaluate the drug's suitability because baclofen may worsen symptoms of certain diseases or cause new health problems.
Additionally, use of baclofen oral granules may increase the risk of ovarian cysts. Although the risk is relatively low, patients should discuss their risk profile with their doctor and have regular checkups to ensure good health.
Special caution is required when using baclofen oral granules in female patients who are pregnant or planning to become pregnant, breastfeeding or planning to breastfeed. Medications may be passed to the fetus or infant through the placenta or breast milk, causing potential harm to the fetus or infant. Therefore, before use, female patients should be sure to inform their doctor of their pregnancy or breastfeeding status so that the doctor can evaluate the risks and benefits of taking the drug.
Patients should avoid drinking alcohol while taking baclofen oral granules. At the same time, because the drug may affect the patient's reaction ability and judgment, patients should avoid driving or participating in other dangerous activities while taking the drug to ensure the safety of themselves and others.
In addition, drowsiness may be increased when baclofen oral granules are combined with other medications that may make patients drowsy (such as opioids, sleeping pills, muscle relaxants, or medications to treat anxiety or epilepsy). This increased drowsiness may cause confusion, slow reaction times, and even accidents. Therefore, before using these drugs, patients should consult their doctor to understand drug interactions and ensure the safety of the medication.
Finally, patients should tell their doctors about all other medications they take, including prescription drugs, over-the-counter medications, vitamins, and herbal products. Drug-drug interactions may affect the efficacy and safety of baclofen oral granules. For example, certain medications may increase or decrease the concentration of baclofen in the body, affecting its therapeutic effectiveness. Therefore, patients must truthfully tell their doctors about their medication so that doctors can make correct medication decisions.
In short, when using baclofen oral granules, patients should strictly abide by the doctor's instructions, understand the contraindications and precautions of the drug, and ensure the safety and effectiveness of the drug. If you have any questions or discomfort, you should contact your doctor promptly and seek professional medical advice.
References:
https://www.drugs.com/newdrugs/fda-approves-lyvispah-baclofen-oral-granules-spasticity-5730.html
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)